|Articles|February 4, 2011

Are You EHR-Ready? Quiz

Is your practice ready to begin the EHR transition? Take this simple quiz to find out.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe

Related Content

Brain Trust: The Placebo Effect as a Clinical Tool, A Discussion With Walter A. Brown, MD

ByJoseph F. Goldberg, MD,Walter A. Brown, MD

July 23rd 2026

Podcast: Finding Joy and Balance in Busy Lives as Mental Health Practitioners

ByFrank A. Clark, MD,Tiffani L. Bell Washington, MD, MPH, MBA, FAPA, FOMA, FAMWA, FACLM, DFAACAP

July 15th 2026

Podcast: Why Psychiatry’s Growing Tribalism Harms Care

ByErin Crown, MHS, PA-C, Psych-CAQ,John J. Miller, MD

July 2nd 2026

Tribalism in Psychiatry: On the Mind of John J. Miller, MD

ByErin Crown, MHS, PA-C, Psych-CAQ,John J. Miller, MD

June 30th 2026

Increasing Access to Mental Health Care: Easing Friction Points

ByLindsay Oberleitner, PhD

May 19th 2026

Latest CME

Video

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

John Koo, MD; T.J. Chao, MPAS, PA-C

Video

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Ilan Melnick, MD; Linda Collado, MD, DABPN, FAPA; Maria Collado, MD, FAPA

Video

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Patricia Junquera, MD; Maria Collado, MD; Erin C. Crown, MHSPAS, PA-C, Psych-CAQ

Video

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Juan D. Oms, MD, FAPA; Linda Collado, MD, DABPN, FAPA; Ginger Shupe, MD

Video

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Gus Alva, MD, DFAPA; Ilan Melnick, MD

Video

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Jason Kellogg, MD; Gus Alva, MD, DFAPA; Melanie Barrett, MD; Yvette Elpidio, MSN, FNP-C

Are You EHR-Ready? Quiz

Related Content

Brain Trust: The Placebo Effect as a Clinical Tool, A Discussion With Walter A. Brown, MD

Podcast: Finding Joy and Balance in Busy Lives as Mental Health Practitioners

Podcast: Why Psychiatry’s Growing Tribalism Harms Care

Tribalism in Psychiatry: On the Mind of John J. Miller, MD

Increasing Access to Mental Health Care: Easing Friction Points

Latest CME

(CME Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Clear Skin, Clear Mind: Integrating Mental Health into Psoriasis Care

Expert Illustrations & Commentary: Visualizing the Role of Novel Muscarinic Agents in the Management of Schizophrenia

Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Expert Illustrations & Commentary: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

(CPE Track) SoCal Psych 2025: Overcoming Barriers to Long-Acting Injectable Agents in Schizophrenia

Live Expert Illustrations & Commentary™: Visualizing Novel Therapeutic Targets for Patients with Major Depressive Disorder

Trending on Psychiatric Times

FDA Approves Centanafadine for ADHD in Children, Adolescents, and Adults